Home   »   Short-Term Regimen for TB

Short-Term Regimen for TB

Table of Contents

Context

The Union Health Ministry has recently approved the introduction of a new treatment regimen for multidrug-resistant tuberculosis (BPaL Regimen) in India.

 MDR-TB: A Growing Concern

  • MDR-TB occurs when TB germs become resistant to rifampicin and isoniazid, two major TB drugs.
  • Mortality Risk: Carries a 30-40% risk of death.
  • Global Burden (2023):
    • 1,75,923 cases reported to WHO.
    • India’s share: 27% of global MDR-TB cases.
  • Causes: Lack of adherence to TB treatment & Misuse of TB drugs through improper regimens.

Issues with Existing TB Treatments

  • Drug-Sensitive (DS) TB: Treatment duration is 6 months, involving 4 drugs initially.
  • Drug-Resistant (DR) TB:
    • Longer treatment: 18 months or more.
    • Higher pill burden: At least five drugs.
      • Severe side effects (hearing loss, depression and menstrual disruptions).

Shorter Regimens: The BPaL Regimen

  • Components: Bedaquiline, Pretomanid Linezolid (BPaL), Duration – 6 months.

●      Advantages:

  • Reduced treatment duration.
  • Improved adherence due to lower pill burden.
  • Decreased economic burden on patients.

 

Tuberculosis (TB)

●       It is a bacterial infection spread through inhaling tiny droplets from the coughs or sneezes of an infected person.

○       TB is caused by a bacterium called Mycobacterium tuberculosis, belonging to the Mycobacteriaceae family.

●       Transmission: TB spreads from person to person through the air.

●       Types:

○       Pulmonary TB: Affects the lungs

○       Extra-Pulmonary TB: Affects other organs.

●       TB is a treatable and curable disease.

●       Treatment:

○       Vaccine: Currently, Bacille Calmette-Guérin (BCG) is the only licensed vaccine available for the prevention of TB.

○       Major drugs (4): Isoniazid (INH), Rifampicin, Pyrazinamide & Ethambutol.

●       TB Elimination Targets:

○       India – National TB Elimination Programme (NTEP) to eliminate TB by 2025.

○       Globally – End TB Strategy of WHO to eliminate TB by 2030.

Ready to turn your UPSC dreams into reality? Join the trusted StudyIQ UPSC Foundation P2I Live Hinglish Batches today! Our expert-led courses are designed to build a solid foundation while keeping you updated with the latest exam trends. Contact us now to enroll and get one step closer to cracking the UPSC exam with confidence.

Sharing is caring!

About the Author
Piyush
Piyush
Author

Greetings! I'm Piyush, a content writer at StudyIQ. I specialize in creating enlightening content focused on UPSC and State PSC exams. Let's embark on a journey of discovery, where we unravel the intricacies of these exams and transform aspirations into triumphant achievements together!